
TRAIN Newsletter — July 2024

An Update from MI Health—July 2024

FasterCures Quarterly Update—July 2024

Milken Institute Statement on Newly Released FDA Guidance on Diversity Action Plans to Improve Enrollment of Participants from Underrepresented Populations in Clinical Trials

Tech Regulation Digest: Antitrust Scrutiny: Apple's Evolving Regulatory Strategies

Milken Institute Statement on the US House Passage of the Financial Innovation and Technology for the 21st Century Act

Comments on Collection of Race and Ethnicity Data in Clinical Trials and Clinical Studies for FDA-Regulated Medical Products, Federal Register Docket FDA-2016-D-3561

The 2024-2025 FasterCures LeadersLink Cohort

TRAIN Newsletter — April 2024

Tech Regulation Digest: CHIPS Act—Fueling the US Semiconductor Surge
